Comparative activity of garenoxacin (BMS284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001).
Comparative activity of garenoxacin (BMS284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001). by Jones RN, Biedenbach DJ published in Diagn. Microbiol. Infect. Dis. 2003; 45 (4): 273-278
